{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:11:37Z","timestamp":1776395497885,"version":"3.51.2"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.sxmr.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T05:03:15Z","timestamp":1594443795000},"page":"434-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intralesional Injection Therapy and Atypical Peyronie's Disease: A Systematic Review"],"prefix":"10.1093","volume":"9","author":[{"given":"Edward J.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farouk M.","family":"El-Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2020.05.003_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00345-019-02815-6","article-title":"A\u00a0review of inflammation and fibrosis: implications for the pathogenesis of Peyronie\u2019s disease","volume":"38","author":"Patel","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11934-018-0800-5","article-title":"Contemporary review of Peyronie\u2019s disease treatment","volume":"19","author":"Capoccia","year":"2018","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.sxmr.2020.05.003_bib3","first-page":"425","article-title":"Sur quelques obstacles qui s\u2019opposent \u00e0 l\u2019\u00e8jaculation naturelle de la semence","volume":"1","author":"de la Peyronie","year":"1743","journal-title":"Mem Acad R Chir"},{"key":"10.1016\/j.sxmr.2020.05.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/282503","article-title":"A\u00a0population-based study of Peyronie\u2019s disease: prevalence and treatment Patterns in the United States","volume":"2011","author":"DiBenedetti","year":"2011","journal-title":"Adv Urol"},{"issue":"6 Part 1","key":"10.1016\/j.sxmr.2020.05.003_bib5","first-page":"2350","article-title":"Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.ijir.3900727","article-title":"Prevalence of Peyronie\u2019s disease in men over 50-y-old from Southern Brazil","volume":"13","author":"Rhoden","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie\u2019s disease: results of a large survey: prevalence OF PEYRONIE\u2019S disease","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2020.05.003_bib8","first-page":"653","article-title":"Psychological Impact of Peyronie\u2019s disease: a review","volume":"10","author":"Nelson","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib9","first-page":"285","article-title":"Proposal: trauma as the cause of the Peyronie\u2019s Lesion","volume":"157","author":"CJJr","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib10","first-page":"1388","article-title":"Penile trauma: an etiologic factor in Peyronie\u2019s disease and erectile dysfunction","volume":"158","author":"Jarow","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib11","first-page":"186","article-title":"Trauma as the cause of Peyronie\u2019s disease: penile fracture as a model of trauma","volume":"172","author":"Zargooshi","year":"2004","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5534\/wjmh.17033","article-title":"Collagenase Clostridium histolyticum in the treatment of Peyronie\u2019s disease: review of a minimally invasive treatment option","volume":"35","author":"Gabrielson","year":"2017","journal-title":"World J Mens Health"},{"key":"10.1016\/j.sxmr.2020.05.003_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1871528111312010009","article-title":"Peironimev-Plus\u00ae in the treatment of chronic inflammation of tunica albuginea (Peyronie\u2019s Disease). Results of a Controlled Study","volume":"12","author":"Paulis","year":"2013","journal-title":"Inflamm Allergy-drug Targets"},{"key":"10.1016\/j.sxmr.2020.05.003_bib14","first-page":"1391","article-title":"Peyronie\u2019s disease is associated with an increase in transforming growth factor-beta protein expression","volume":"158","author":"El-Sakka","year":"1997","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","article-title":"Histological and ultrastructural alterations in an animal model of Peyronie\u2019s disease","volume":"81","author":"El-Sakka","year":"1998","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2020.05.003_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.aju.2013.06.006","article-title":"The pathophysiology of Peyronie\u2019s disease","volume":"11","author":"El-Sakka","year":"2013","journal-title":"Arab J Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.ijir.3900873","article-title":"Gene expression in Peyronie\u2019s disease","volume":"14","author":"Gonzalez-Cadavid","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.sxmr.2015.10.002","article-title":"The Genetic Basis of Peyronie Disease: A Review","volume":"4","author":"Herati","year":"2016","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.05.003_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.ijir.3900875","article-title":"Pathophysiology of Peyronie\u2019s disease","volume":"14","author":"Moreland","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.sxmr.2016.07.004","article-title":"Review of Management Options for Patients With Atypical Peyronie\u2019s Disease","volume":"5","author":"Yafi","year":"2017","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.05.003_bib21","first-page":"302","article-title":"Peyronie\u2019s Disease in Teenagers","volume":"9","author":"Tal","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.sxmr.2018.09.007","article-title":"Review of Management Options for Active-Phase Peyronie\u2019s Disease","volume":"7","author":"Brimley","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.05.003_bib23","first-page":"1075","article-title":"A\u00a0Retrospective Review of 307 Men With Peyronie\u2019s Disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib24","first-page":"2359","article-title":"The Management of Peyronie\u2019s Disease: Evidence-based 2010 Guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ijir.2011.24","article-title":"Relationship between penile fracture and Peyronie\u2019s disease: a prospective study","volume":"23","author":"Acikgoz","year":"2011","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib26","first-page":"1985","article-title":"The Chronology of Depression and Distress in Men with Peyronie\u2019s Disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib27","first-page":"506","article-title":"Acute Phase Peyronie\u2019s Disease Management with Traction Device: A Nonrandomized Prospective Controlled Trial with Ultrasound Correlation","volume":"11","author":"Mart\u00ednez-Salamanca","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib28","first-page":"2492","article-title":"Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie\u2019s Disease","volume":"12","author":"Yafi","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib29","first-page":"199","article-title":"Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib30","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.sxmr.2020.05.003_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/andr.12368","article-title":"Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie\u2019s disease: preliminary results from a prospective, double-blinded, randomized study","volume":"5","author":"Favilla","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.sxmr.2020.05.003_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/and.12178","article-title":"Combination of intralesional verapamil and oral antioxidants for Peyronie\u2019s disease: a prospective, randomised controlled study","volume":"46","author":"Favilla","year":"2014","journal-title":"Andrologia"},{"key":"10.1016\/j.sxmr.2020.05.003_bib33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of Intralesional Verapamil to Dissolve Peyronie\u2019s Disease Plaque: A Long-Term Single-Blind Study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.05.003_bib34","article-title":"Minimally Invasive Therapy Using Intralesional OnabotulinumtoxinA in Peyronie\u2019s Disease","volume":"12","author":"Mu\u00f1oz-Rangel","year":"2015","journal-title":"Urol J [Internet]"},{"key":"10.1016\/j.sxmr.2020.05.003_bib35","first-page":"621","article-title":"Experience With Intraplaque Injection of Verapamil for Peyronie\u2019s Disease","volume":"168","author":"Levine","year":"2002","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5534\/wjmh.190026","article-title":"How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie\u2019s Disease Receiving Collagenase Clostridium Histolyticum Therapy?","volume":"38","author":"Cocci","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.sxmr.2020.05.003_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2019.01.055","article-title":"Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie\u2019s Disease Men With Ventral Curvatures","volume":"129","author":"Alom","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.05.003_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.urology.2016.04.049","article-title":"Peyronie\u2019s Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms","volume":"94","author":"Yang","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.05.003_bib39","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI102861","article-title":"Isolation and Characterization of Proteinase and Collagenase from Cl","volume":"32","author":"Mandl","year":"1953","journal-title":"Histolyticum J Clin Invest"},{"key":"10.1016\/j.sxmr.2020.05.003_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.sxmr.2017.03.005","article-title":"Collagenase Clostridium Histolyticum in the Treatment of Urologic Disease: Current and Future Impact","volume":"6","author":"Gabrielson","year":"2018","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.sxmr.2020.05.003_bib41","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/bi00843a031","article-title":"Purification and partial characterization of collagenolytic enzymes from Clostridium histolyicum","volume":"7","author":"Kono","year":"1968","journal-title":"Biochemistry"},{"key":"10.1016\/j.sxmr.2020.05.003_bib42","article-title":"Collagenase Clostridium Histolyticum Degrades Type I and III Collagen while Sparing Type IV Collagen in\u00a0vitro ini Peyronie\u2019s Plaque Explants","volume":"191","author":"Levine","year":"2014","journal-title":"J\u00a0Urol [Internet]"},{"key":"10.1016\/j.sxmr.2020.05.003_bib43","series-title":"Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie\u2019s Disease","year":"2011"},{"key":"10.1016\/j.sxmr.2020.05.003_bib44","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00007632-198507000-00010","article-title":"Effects of Collagenase on Nerve Tissue: An Experimental Study on Acute and Long-Term Effects in Rabbits","volume":"10","author":"Rydevik","year":"1985","journal-title":"Spine"},{"key":"10.1016\/j.sxmr.2020.05.003_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02844318909067503","article-title":"Microvascular Response to Locally Injected Collagenase: An Experimental Investigation in Hamsters and Rabbits","volume":"23","author":"Rydevik","year":"1989","journal-title":"Scand J Plast Reconstr Surg"},{"key":"10.1016\/j.sxmr.2020.05.003_bib46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1517\/14712598.2010.510509","article-title":"Collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"10","author":"Desai","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.sxmr.2020.05.003_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00345-019-02812-9","article-title":"A\u00a0modified technique for intralesional injection of collagenase Clostridium histolyticum for Peyronie\u2019s disease results in reduced procedural morbidity using a standardized hematoma classification rubric","volume":"38","author":"Amighi","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib48","first-page":"S55","article-title":"116 Positive Results with Collagenase Clostridium histolyticum Treatment in Two Patients with Ventral Penile Curvature Due to Peyronie\u2019s Disease","volume":"13","author":"Milam","year":"2016","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2020.01.035","article-title":"The Influence of Indentation Deformity on Outcomes With Intralesional Collagenase Clostridium Histolyticum Monotherapy for Peyronie\u2019s Disease","volume":"139","author":"Ziegelmann","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.05.003_bib50","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bju.13932","article-title":"Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie\u2019s disease using a new modified shortened protocol","volume":"120","author":"Abdel Raheem","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.sxmr.2020.05.003_bib51","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1073\/pnas.93.11.5478","article-title":"Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix","volume":"93","author":"Roth","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.sxmr.2020.05.003_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie\u2019s disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/tau.2016.03.15","article-title":"Injectable therapy for Peyronie\u2019s disease","volume":"5","author":"Chong","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib54","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.69.4.892","article-title":"Inhibition of Collagen Secretion from Bone and Cultured Fibroblasts by Microtubular Disruptive Drugs","volume":"69","author":"Diegelmann","year":"1972","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.sxmr.2020.05.003_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1083\/jcb.62.2.390","article-title":"Effects of antimicrotubular agents on the secretion of collagen: A biochemical and morphological study","volume":"62","author":"Ehrlich","year":"1974","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0022-4804(90)90197-A","article-title":"Calcium antagonists retard extracellular matrix production in connective tissue equivalent","volume":"49","author":"Lee","year":"1990","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0952-3278(92)90085-W","article-title":"The diminished extracellular matrix production induced by isradipine, a calcium channel blocker, is completely abolished by cyclooxygenase inhibition","volume":"45","author":"Fitscha","year":"1992","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.sxmr.2020.05.003_bib58","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1083\/jcb.98.5.1662","article-title":"Changes in cell shape correlate with collagenase gene expression in rabbit synovial fibroblasts","volume":"98","author":"Aggeler","year":"1984","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib59","first-page":"1522","article-title":"Intralesional Verapamil Injection for the Treatment of Peyronie\u2019s Disease","volume":"151","author":"Levine","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.acuro.2018.08.005","article-title":"Ten-year experience with multimodal treatment for acute phase Peyronie\u2019s disease: A real life clinical report","volume":"43","author":"Gallo","year":"2019","journal-title":"Actas Urol Esp Engl Ed"},{"key":"10.1016\/j.sxmr.2020.05.003_bib61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2015.03.010","article-title":"Intralesional Injections for Early Peyronie Disease: Standardized Assessment and Analysis of Predictive Factors for Treatment Response","volume":"86","author":"Wolff","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2020.05.003_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00365599109024539","article-title":"Regulation of the Proliferation and Biosynthetic Activities of Cultured Human Peyronie\u2019s Disease Fibroblasts by Interferons-Alpha, -Beta and -Gamma","volume":"25","author":"Duncan","year":"1991","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.ijir.3900414","article-title":"Stimulation of collagen production in an in\u00a0vitro model for Peyronie\u2019s disease","volume":"11","author":"Ahuja","year":"1999","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib64","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1111\/1523-1747.ep12874789","article-title":"Interferons and Collagen Production","volume":"95","author":"Granstein","year":"1990","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib65","first-page":"394","article-title":"Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon \u03b1-2b for Minimally Invasive Treatment for Peyronie\u2019s Disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.SMJ.0000056658.60032.D3","article-title":"Intralesional Interferon-\u03b1-2B Injections for the Treatment of Peyronie\u2019s Disease","volume":"97","author":"Dang","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.sxmr.2020.05.003_bib67","first-page":"709","article-title":"The Impact of Intralesional Interferon \u03b1-2b Injection Therapy on Penile Hemodynamics in Men with Peyronie\u2019s Disease","volume":"2","author":"Kendirci","year":"2005","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2020.05.003_bib68","first-page":"2194","article-title":"Outcomes of Intralesional Interferon-\u03b12B for the Treatment of Peyronie Disease","volume":"190","author":"Trost","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib69","first-page":"754","article-title":"The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie\u2019s Disease","volume":"194","author":"Yafi","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib70","first-page":"1704","article-title":"Intralesional Injection of Interferon-\u03b12b Improves Penile Curvature in Men with Peyronie\u2019s Disease Independent of Plaque Location","volume":"194","author":"Stewart","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib71","first-page":"745","article-title":"Peyronie\u2019s Disease: AUA Guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.sxmr.2020.05.003_bib73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jprot.2014.01.016","article-title":"Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress","volume":"99","author":"Yu","year":"2014","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.sxmr.2020.05.003_bib74","first-page":"1713","article-title":"Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis","volume":"27","author":"Takahashi","year":"2000","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib75","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.phrs.2006.06.002","article-title":"Hyaluronic acid counteracts interleukin-1-induced inhibition of collagen biosynthesis in cultured human chondrocytes","volume":"54","author":"Karna","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.sxmr.2020.05.003_bib76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1526-4610.43.7s.4.x","article-title":"Synaptic Transmission: Inhibition of Neurotransmitter Release by Botulinum Toxins","volume":"43","author":"Dolly","year":"2003","journal-title":"Headache J Head Face Pain"},{"key":"10.1016\/j.sxmr.2020.05.003_bib77","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3342\/ceo.2009.2.1.20","article-title":"Effect of botulinum toxin type a on a rat surgical wound model","volume":"2","author":"Lee","year":"2009","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.sxmr.2020.05.003_bib79","first-page":"284","article-title":"Effect of botulinum toxin type A injection on hypertrophic scar in rabbit ear model","volume":"25","author":"Wang","year":"2009","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi Zhonghua Zhengxing Waike Zazhi Chin J Plast Surg"},{"key":"10.1016\/j.sxmr.2020.05.003_bib80","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00266-011-9690-3","article-title":"Botulinum Toxin Type A Inhibits Connective Tissue Growth Factor Expression in Fibroblasts Derived From Hypertrophic Scar","volume":"35","author":"Xiao","year":"2011","journal-title":"Aesthet Plast Surg"},{"key":"10.1016\/j.sxmr.2020.05.003_bib81","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1090820X13482938","article-title":"Effects of Botulinum Toxin Type A on Expression of Genes in Keloid Fibroblasts","volume":"34","author":"Xiaoxue","year":"2014","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.sxmr.2020.05.003_bib82","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF02551115","article-title":"Peyronie\u2019s disease: Intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging","volume":"29","author":"Polat","year":"1997","journal-title":"Int Urol Nephrol"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052120300457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052120300457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:38:02Z","timestamp":1672774682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052120300457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2050052120300457"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2020.05.003","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intralesional Injection Therapy and Atypical Peyronie's Disease: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}